Paramètres biologiques   ARV+Placebo ARV+«Spiruline plus» Placebo «Spiruline plus» p (variance)
Globules Blancs <Normal 12 (42.8%) 6(23.1%) 3(18.75%) 3(23.1%) 0.450
(n=83)  Normal 15(53.6) 20(76.9%) 13(81.25%) 9(69.2%)  
  >Normal 1(3.6%) - - 1(7.7%)  
Neutrophiles <Normal 9(32.1%) 8(30.8%) 10(62.5%) 7(53.8%) 0.043
(n=82)  Normal 18(64.3%) 18(69.2%) 6(37.5%) 6(46.1%)  
  >Normal 1(3.6%) - - -  
Lymphocytes <Normal 4(14.3%) - - - 0.205
(n=82)  Normal 22(78.6%) 25(100%) 14(87.5%) 13(100%)  
  >Normal 2(7.1%)   2(12.5%)    
Monocytes <Normal 5 (17.8%) 5(19.2%) - - 0.356
(n=82)  Normal 10(35.7%) 6(23.1%) 3(18.8%) 3(25%)  
  >Normal 13(46.5) 15(57.7%) 13(81.2%) 9(75%)  
Eosinophiles <Normal 20(71.4%) 21(84%) 11(68.7) 2(15.4%) 0.07
(n=82) >Normal 8(28.6%) 4(26%) 5(31.3%) 11(84.6%)  
Basophiles <Normal 28(100%) 25(96.1%) 16(100%) 13(100%) NC
(n=83) > Normal - 1(3.9%) - -  
Globules rouges <Normal 22(78.6%) 26 (100%) 6(37.5%) 8(66.7%) 0.112
(n=82)  Normal 6(21.4%) - 10(62.5%) 4(33.3%)  
  >Normal - - - -  
Hémoglobine <Normal 6(21.4%) 6(23.1%) 4(25%) 8(66.7%) 0.133
(n=82)  Normal 22(78.6%) 20(76.9%) 12(75%) 4(33.3%)  
  >Normal - - - -  
Hématocrite <Normal 17(60.7%) 16(64%) 9(56.2%) 9(69.2%) 0.112
(n=82)  Normal 11(39.3%) 9(36%) 6(37.5%) 4(30.8%)  
  >Normal - - 1(6.3%) -  
CCMH <Normal - 1(4%) - -  
(n=82)  Normal 2((7.1%) - 8(50%) 3(25%)  
  >Normal 26(82.9%) 25(96%) 8(50%) 9(75%)  
TGMH <Normal - - 1(6.7%) -  
(n=82)  Normal 1(3.6%) 4(15.4%) 2(13.3%) 1(8.3%)  
  >Normal 27(96.4%) 22(84.6%) 12(80%) 11(91.7%)  
Plaquettes <Normal 3(10.7%) 5(19.2%) 4(25%) - 0.848
(n=82)  Normal 25(89.3%) 21(80.8%) 12(75%) 13(100%)  
  >Normal - - - -  
VGM <Normal - 1(3.8%) 2(12.5%) 1(8.3%)  
(n=82)  Normal 9(32.1%) 10(38.5%) 12(75%) 8(66.6%)  
  >Normal 19(67.8%) 15(57.7%) 2(12.5%) 3(25%)  
Table 8: Hematological features in the treatment group and normal intervals to 6 months follow-up.